Search filters

List of works by Karen Hayhurst

A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia

scientific article published on 01 May 2007

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine

scientific article published on 18 December 2007

Associations between participant characteristics, digital intervention engagement and recovery outcomes for participants accessing ‘Breaking Free Online’ at ‘Change Grow Live’

scientific article published on 02 December 2020

Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy

scientific article published in July 2007

Development of a resource allocation formula for substance misuse treatment services.

scientific article

Drug spend and acquisitive offending by substance misusers

scientific article published on 3 November 2012

Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes

scientific article published on 25 July 2013

Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.

scientific article published on 12 June 2013

Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users

scientific article published on 16 August 2017

Pathways through opiate use and offending: A systematic review

scientific article published on 19 October 2016

Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophrenia

scientific article published on 21 August 2008

Patients' subjective rating of mental health improvement in a randomised controlled trial.

scientific article published on 15 July 2015

Practicalities of running non-commercial clinical drug trials in the NHS: A resource based on the experiences of the CUtLASS study (Cost utility of the latest antipsychotics in severe schizophrenia)

Prevalence of recent fentanyl use among treated users of illicit opioids in England: based on piloted urine drug screens

scientific article published on 16 December 2018

Quantifying crime associated with drug use among a large cohort of sanctioned offenders in England and Wales

scientific article published on 8 September 2015

Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial

scientific article

Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment

scientific article published on 31 October 2011

Short-Term Outcomes for Opiate and Crack Users Accessing Treatment: The Effects of Criminal Justice Referral and Crack Use.

scientific article published on 17 November 2015

The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement

scientific article published on August 2011

The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation

scientific article

Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma

scientific article published on 9 January 2018

Validity of subjective versus objective quality of life assessment in people with schizophrenia

scientific article